These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33600264)

  • 41. Clinical features, early treatment responses, and outcomes of pediatric acute lymphoblastic leukemia in China with or without specific fusion transcripts: a single institutional study of 1,004 patients.
    Gao C; Zhao XX; Li WJ; Cui L; Zhao W; Liu SG; Yue ZX; Jiao Y; Wu MY; Li ZG
    Am J Hematol; 2012 Nov; 87(11):1022-7. PubMed ID: 22911440
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SMYD2 is highly expressed in pediatric acute lymphoblastic leukemia and constitutes a bad prognostic factor.
    Sakamoto LH; Andrade RV; Felipe MS; Motoyama AB; Pittella Silva F
    Leuk Res; 2014 Apr; 38(4):496-502. PubMed ID: 24631370
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study.
    Conter V; Bartram CR; Valsecchi MG; Schrauder A; Panzer-Grümayer R; Möricke A; Aricò M; Zimmermann M; Mann G; De Rossi G; Stanulla M; Locatelli F; Basso G; Niggli F; Barisone E; Henze G; Ludwig WD; Haas OA; Cazzaniga G; Koehler R; Silvestri D; Bradtke J; Parasole R; Beier R; van Dongen JJ; Biondi A; Schrappe M
    Blood; 2010 Apr; 115(16):3206-14. PubMed ID: 20154213
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multiple drug resistance protein (MDR-1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) gene expression in childhood acute lymphoblastic leukemia.
    Valera ET; Scrideli CA; Queiroz RG; Mori BM; Tone LG
    Sao Paulo Med J; 2004 Jul; 122(4):166-71. PubMed ID: 15543372
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of three factors (ABCB1 gene expression, steroid response, early response at day + 8) on the response to induction in patients with acute lymphoblastic leukemia.
    Ramos-Peñafiel C; Olarte-Carrillo I; Maldonado RC; de la Cruz Rosas A; Collazo-Jaloma J; Martínez-Tovar A
    Ann Hematol; 2020 Nov; 99(11):2629-2637. PubMed ID: 32980890
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of certain leukemia/lymphoma related microRNAs and its correlation with prognosis in childhood acute lymphoblastic leukemia.
    Nemes K; Csóka M; Nagy N; Márk Á; Váradi Z; Dankó T; Kovács G; Kopper L; Sebestyén A
    Pathol Oncol Res; 2015 Jul; 21(3):597-604. PubMed ID: 25388103
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Concept and interim result of the ALL-BFM 90 therapy study in treatment of acute lymphoblastic leukemia in children and adolescents: the significance of initial therapy response in blood and bone marrow].
    Schrappe M; Reiter A; Sauter S; Ludwig WD; Wörmann B; Harbott J; Bender-Götze C; Dörffel W; Dopfer R; Frey E
    Klin Padiatr; 1994; 206(4):208-21. PubMed ID: 7526027
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The correlation of long non-coding RNA intersectin 1-2 with disease risk, disease severity, inflammation, and prognosis of acute ischemic stroke.
    Zhang Y; Niu C
    J Clin Lab Anal; 2020 Feb; 34(2):e23053. PubMed ID: 31647141
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased methylation upstream of the MEG3 promotor is observed in acute myeloid leukemia patients with better overall survival.
    Sellers ZP; Bolkun L; Kloczko J; Wojtaszewska ML; Lewandowski K; Moniuszko M; Ratajczak MZ; Schneider G
    Clin Epigenetics; 2019 Mar; 11(1):50. PubMed ID: 30876483
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Prognostic factors for childhood acute non-mature B-lymphoblastic leukemia].
    Jiang H; Gu LJ; Xue HL; Tang JY; Chen J; Pan C; Chen J; Xu C; Dong L; Zhou M
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Jun; 10(3):290-4. PubMed ID: 18554450
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical significance of long noncoding RNA maternally expressed gene 3 in acute promyelocytic leukemia.
    Jiang M; Wang Q; Yu G; Wan J; Liu S; Zhang Z; Le A
    Int J Lab Hematol; 2021 Aug; 43(4):693-698. PubMed ID: 33372415
    [TBL] [Abstract][Full Text] [Related]  

  • 52. BCL2L12 improves risk stratification and prediction of BFM-chemotherapy response in childhood acute lymphoblastic leukemia.
    Avgeris M; Stamati L; Kontos CK; Piatopoulou D; Marmarinos A; Xagorari M; Baka M; Doganis D; Anastasiou T; Kosmidis H; Gourgiotis D; Scorilas A
    Clin Chem Lab Med; 2018 Nov; 56(12):2104-2118. PubMed ID: 30016275
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcome of Reinduction Chemotherapy with a Modified Dose of Idarubicin for Children with Marrow-Relapsed Acute Lymphoblastic Leukemia: Results of the Childhood Acute Lymphoblastic Leukemia (CALL)-0603 Study.
    Koh KN; Im HJ; Kim H; Kang HJ; Park KD; Shin HY; Ahn HS; Lee JW; Yoo KH; Sung KW; Koo HH; Lim YT; Park JE; Park BK; Park HJ; Seo JJ
    J Korean Med Sci; 2017 Apr; 32(4):642-649. PubMed ID: 28244291
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of microRNA-210 on prognosis and response to chemotherapeutic drugs in pediatric acute lymphoblastic leukemia.
    Mei Y; Gao C; Wang K; Cui L; Li W; Zhao X; Liu F; Wu M; Deng G; Ding W; Jia H; Li Z
    Cancer Sci; 2014 Apr; 105(4):463-72. PubMed ID: 24720529
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of age, leukocyte count and day 21-bone marrow response to chemotherapy on the long-term outcome of children with philadelphia chromosome-positive acute lymphoblastic leukemia in the pre-imatinib era: results of the FRALLE 93 study.
    Gandemer V; Auclerc MF; Perel Y; Vannier JP; Le Gall E; Demeocq F; Schmitt C; Piguet C; Stephan JL; Lejars O; Debre M; Jonveaux P; Cayuela JM; Chevret S; Leverger G; Baruchel A;
    BMC Cancer; 2009 Jan; 9():14. PubMed ID: 19144139
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic Implication of MIF Gene Expression in Childhood Acute Lymphoblastic Leukemia.
    Sharaf-Eldein M; Elghannam D; Elderiny W; Abdel-Malak C
    Clin Lab; 2018 Sep; 64(9):1429-1437. PubMed ID: 30274020
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Absolute lymphocyte count at the end of induction therapy is a prognostic factor in childhood acute lymphoblastic leukemia.
    Hirase S; Hasegawa D; Takahashi H; Moriwaki K; Saito A; Kozaki A; Ishida T; Yanai T; Kawasaki K; Yamamoto N; Kubokawa I; Mori T; Hayakawa A; Nishimura N; Nishio H; Iijima K; Kosaka Y
    Int J Hematol; 2015 Nov; 102(5):594-601. PubMed ID: 26440971
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Prognostic value of the initial response to corticosteroids for children with acute lymphoblastic leukemia].
    Klimza MJ; Sońta-Jakimczyk DJ
    Wiad Lek; 2005; 58(11-12):622-5. PubMed ID: 16594471
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combined use of peripheral blood blast count and platelet count during and after induction therapy to predict prognosis in children with acute lymphoblastic leukemia.
    Dai Q; Shi R; Zhang G; Yang H; Wang Y; Ye L; Peng L; Guo S; He J; Jiang Y
    Medicine (Baltimore); 2021 Apr; 100(15):e25548. PubMed ID: 33847682
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (BCRP) genes and clinical outcome in childhood acute lymphoblastic leukemia.
    Kourti M; Vavatsi N; Gombakis N; Sidi V; Tzimagiorgis G; Papageorgiou T; Koliouskas D; Athanassiadou F
    Int J Hematol; 2007 Aug; 86(2):166-73. PubMed ID: 17875533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.